China CDE Approved First Universal CAR-T IND ! : vimarsana.c

/PRNewswire/ -- On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T)...

Related Keywords

China , Decheng , Guangdong , Nanjing , Jiangsu , , Immunotherapy Excellence Center , National Intellectual Property Management Enterprise , China National Drug Administration Review Center , Unicorn Enterprises , Innovation Talents Program Of Jiangsu Province , National Science , Bioheng Biotech Co Ltd , Hillhouse Venture Capital , Decheng Capital , Octagon Capital , Jiangsu Province , Nanjing High Level Entrepreneurial Talent Plan , Nanjing Expert Studio , Nanjing Bioheng Biotech Co , Td ,